Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntelliAM AI Regulatory News (INT.PL)

Share Price Information for IntelliAM AI (INT.PL)

Share Price is delayed by 15 minutes
Get Live Data
80.00    0.00 (0.00%)
Bid:
70.00
Ask:
90.00
Spread: 20.00 (28.571%)
Market Cap: £15.68m
INT.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday IntelliAM AI Share Chart

Directorate Change

13 Jan 2025 07:00

RNS Number : 9869S
IntelliAM AI PLC
13 January 2025
 

13 January 2025

 

IntelliAM AI Plc

('IntelliAM' or the 'Company')

 

Board Change

 

IntelliAM AI plc (AQSE: INT), the software company leveraging the power of AI and machine learning in the manufacturing industry, announces a planned change to its board.

 

David Richards MBE, co-founder and non-executive Chairman of the Company, will step down as Chairman and as a director in six months' time, on 3 July 2025, as part of a planned transition. This decision aligns with the board's post-IPO succession plan, which envisaged David's tenure as Chairman lasting for 12 months following the successful public listing of the Company.

 

The board has initiated a formal process to appoint a successor and is confident this will ensure a smooth and seamless transition of leadership. David will remain in the role of Chairman for the next six months to support this process and provide continuity during this planned transition period.

 

David Richards MBE commented:

 

"As Co-Founder of Intelliam AI, I am immensely proud of what we have achieved since the company's inception and during our journey to becoming a listed entity. The decision to step down as Chairman has always been part of our strategic plan, enabling me to focus on my role as Managing Partner of Yorkshire AI Labs, which remains fully committed to supporting Intelliam AI as a 20% shareholder. My belief in the company's vision, strategy, and leadership team is unwavering, and I look forward to continuing to support its success through my ongoing involvement."

 

The Board expresses its sincere gratitude to David for his exceptional leadership, particularly during the critical IPO phase. Further updates regarding the appointment of a new Chairman will be announced in due course.

 

Enquiries:

 

 

IntelliAM AI plc

Tom Clayton, Chief Executive Officer

Daud Khan, Chief Financial Officer

 

+44 114 299 5007

Oberon Capital - AQSE Corporate Adviser and Broker

Adam Pollock

Mike Seabrook

Jessica Cave

 

+44 203 179 5300

Square1 Consulting - Financial PR

David Bick

+44 207 929 5599

+44 7831 381201

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXBLLFFEFLLBBD
12
Date   Source Headline
8th Jul 20267:00 amRNSNew Customer Wins
7th Jul 20267:07 amRNSFundraising to augment growth in US operations
6th Jul 20267:30 amRNSLaunch of Investor Hub
20th May 20267:00 amRNSUS Expansion and CRO Appointment
16th Apr 20267:00 amRNSTrading Update
1st Apr 20267:00 amRNSAcquisition of RBM Lubrications
19th Mar 20267:00 amRNSAppointment of Corporate Adviser and Broker
6th Jan 20267:00 amRNSOrders from New Customer in Frozen Food Vertical
29th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
10th Dec 20258:17 amRNSHolding(s) in Company
2nd Dec 20258:38 amRNSResult of Oversubscribed WRAP Retail Offer
25th Nov 20257:05 amRNSContract
25th Nov 20257:00 amRNSHalf-year Financial Report
24th Nov 202512:35 pmRNSWRAP Retail Offer
24th Nov 202512:30 pmRNSPlacing and Retail Offer
4th Nov 20257:00 amRNSFirst Half Trading Statement
27th Oct 20257:35 amRNSMove from Access to Apex segment
3rd Oct 20253:45 pmRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSContract
24th Sep 20257:00 amRNSContract
12th Sep 20257:00 amRNS-RManufacturing Tech Award 2025
9th Sep 202512:33 pmRNSResult of Annual General Meeting
4th Sep 20257:00 amRNSDirectorate Change
12th Aug 20257:00 amRNSAnnual Financial Report
8th Aug 20253:00 pmRNSHolding(s) in Company
25th Jul 20257:00 amRNS-RAppointment of Vice President of Sales
7th Jul 20257:00 amRNSFinal Results
3rd Jul 20257:00 amRNSStrategic Partnership Agreement with CTC in USA
2nd Jul 20257:00 amRNSContract
1st Jul 20257:00 amRNSDirectorate Change
27th May 20257:00 amRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSTrading Update
2nd May 20257:00 amRNSDirectorate Change
26th Mar 20257:00 amRNS-RSenior Management Team Strengthened
20th Mar 20252:25 pmRNSDirector/PDMR Shareholding
24th Feb 20251:00 pmRNSDeath of a Non-Executive Director
13th Jan 20257:00 amRNSDirectorate Change
18th Dec 20243:57 pmRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSDirector/PDMR Shareholding
16th Dec 20247:00 amRNSDirector/PDMR Shareholding
12th Dec 20244:51 pmRNSDirector/PDMR Shareholding
11th Dec 20247:00 amRNSLetter of Intent Signed
9th Dec 20247:00 amRNSHalf-year Report
6th Nov 20241:13 pmRNSResult of Annual General Meeting
10th Oct 20243:30 pmRNSPosting of Annual Report and Notice of AGM
25th Sep 20247:00 amRNSAnnual Financial Report
16th Sep 20247:00 amRNSContract
7th Aug 20247:00 amRNSContract
11th Jul 20247:00 amRNSContract
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.